OMass Therapeutics

About:

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

Twitter/X: omasstech

Top Investors: Google Ventures, Oxford Science Enterprises, British Patient Capital, Northpond Ventures, Sanofi Ventures

Description:

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.

Total Funding Amount:

128M GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2016-01-01

Contact Email:

info(AT)omass.com

Founders:

Hsin-Yung Yen, Idlir Liko, Jonathan Hopper

Number of Employees:

11-50

Last Funding Date:

2023-05-15

IPO Status:

Private

Industries: